This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Baxter Hosts 2012 Investor Conference

Baxter International Inc. (NYSE:BAX) will host its 2012 Investor Conference today in Chicago, and during the conference, the company plans to provide its five-year long-range financial outlook, update investors on its innovation pipeline, and outline the company’s key growth strategies.

Baxter will highlight its ongoing focus on four key growth vectors during presentations by a number of Baxter executives. These vectors of growth include: optimizing the core business portfolio; advancing the company’s new product pipeline; pursuing and accelerating the pace of business development initiatives; and capitalizing on the opportunity to develop new business models, which include public and private partnerships aimed at improving the quality of and access to care in both developed and emerging markets.

''We continue to be encouraged by the strength of our diversified business model, our ability to innovate, our prospects for growth, and the future of our company,'' says Robert L. Parkinson, Jr., chairman and chief executive officer. ''We are focused on specific growth strategies that will enable us to reward shareholders, while meeting the needs of the patients and customers who rely on our products to save and sustain lives.''

Over its five-year long-range plan, Baxter expects to increase sales approximately 5 percent (excluding the impact of foreign currency) and grow earnings per share in the 7 to 9 percent range, both on a compound annual basis. The company also expects to generate cash flow from operations of approximately $4.5 billion by the year 2017. This strong cash flow performance positions the company to continue to reinvest in the business and return significant value to shareholders through dividends and share repurchases.

Baxter also will showcase numerous research and development initiatives which continue to advance toward commercialization. The company’s new product pipeline includes numerous products and therapies that address the needs of patients in the acute care setting, as well as the needs of patients with chronic conditions who are increasingly being treated in the home.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs